-transparent.png){kind=logo}
The microbiological and clinico-therapeutic efficacy and safety of ceftriaxone were compared with those of cefotaxime in an open randomized trial. Fifty-four adult hospitalized patients (37 males and 17 females) suffering from either acute bronchopneumonia (19) or acute exacerbations of chronic bronchopneumonia (35) have been investigated. Four patients were withdrawn from the trial. Underlying diseases were present in 41 patients. Ceftriaxone was administered at a once-a-day dose of either 1 or 2 g (in 13 and 14 patients, respectively) and cefotaxime at a 2 g twice daily dosing regimen (27 patients), both antibiotics being given for 7-12 days. In the ceftriaxone group, 15 out of the 27 patients were cured (55%) and 9 had a favourable clinical response for a total satisfactory response rate of 88%. The causative pathogen was eliminated in 18 (66%) patients. The results obtained in the cefotaxime group did not differ significantly, but 2 patients were excluded from the study because of in vitro resistance of the causative pathogen isolated. Both drugs were well tolerated: no relevant laboratory changes were registered. The results indicate that ceftriaxone at a dosage of 2 or 1 g daily is at least as effective as cefotaxime given daily at a dosage of 4 g in the treatment of severe lower respiratory tract infections.
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
February 1986,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
January 1992,
Diagnostic microbiology and infectious disease,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
January 1989,
Chemotherapy,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
October 1994,
Fortschritte der Medizin,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
March 1986,
Minerva medica,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
September 1980,
The Journal of antimicrobial chemotherapy,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
December 1983,
International journal of clinical pharmacology, therapy, and toxicology,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
September 1991,
Hospital practice (Office ed.),
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
January 1981,
Chemotherapy,
G F Abbate, and
I Alagia, and
E Giaquinto, and
V Leonessa, and
L Savioli, and
P Altucci, and
M Caputi, and
C Guarino, and
E Micillo, and
E Catena
October 1987,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
